Promising mRNA vaccines years ago emerged from early-stage development, only to stall before proving themselves in clinical trials. Pushed by pandemic urgency across the notorious “Valley of Death,” this platform vastly exceeded expectations and is now poised to transform the vaccine R&D landscape. During the early months of the historic rollout of COVID-19 vaccines, Sabin’s Influenzer Initiative captured reflections by experts and innovators on the past, present and game-changing future of the mRNA platform. Exciting insights from these conversations reveal the potential of mRNA vaccines to protect against future pandemic threats including influenza, as well as to facilitate equitable access to vaccines worldwide.
Featuring Wyss Core Faculty member Pamela Silver along with Amesh Adalja, Benjamin Jones, Teresa Lambe, Daniel Perez, Stacey Schultz-Cherry, David Topham, Eric Topol and Rajeev Venkayya.